Larocca, Cecilia MD*; Shanmugam, Vignesh MD†; Zemmour, David MD,PhD†; Antin, Joseph H. MD‡; Lane, Andrew A.‡
*Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA;
†Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and
‡Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Correspondence: Cecilia Larocca, MD, Assistant Professor, Department of Dermatology, Harvard Medical School Cutaneous Oncology, Dana-Farber Cancer Institute Department of Dermatology, Brigham and Women's Hospital, 41 Avenue Louis Pasteur Suite 216B, Boston, MA 02115 (email: [email protected]).
The authors declare no conflicts of interest.
